Hologic’s Aptima assay secures FDA approval for HPV primary screening
February 5, 2026
With this FDA approval, Hologic now offers three guideline-recommended methods: Pap testing, HPV primary testing, and co-testing.
With this FDA approval, Hologic now offers three guideline-recommended methods: Pap testing, HPV primary testing, and co-testing.
A new type of brain implant may have implications for both brain research and future treatments of neurological diseases such as epilepsy.
An experimental pill called enlicitide slashed levels of low-density lipoprotein (LDL) cholesterol, commonly known as “bad” cholesterol, by up to 60%, according to a new phase three clinical trial published in the New England Journal of Medicine.
Researchers have developed a nasal spray for flu prevention that has shown promising results in preliminary human trials.
Dexcom (NSDQ:DXCM) announced today that it plans to launch an advanced AI-enabled enhancement to its Stelo over-the-counter CGM.
Testing menstrual blood for human papillomavirus (HPV) could be a “robust alternative or replacement” for current cervical cancer screening by a clinician.
A pioneering study marks a major step toward eliminating the need for daily insulin injections for people with diabetes.
An international research team with strong participation from DTU has developed a new biotechnological platform that makes it possible to test and understand advanced cancer treatments much faster and cheaper than before
A patient with complete blindness caused by irreversible optic nerve damage partially recovered natural vision after participating in a clinical trial of electrical stimulation of the visual cortex conducted by researchers.
Two models more accurately replicate the physiology of the liver, offering a new way to test treatments for fat buildup.